How many DEFA14A filings has Zomedica Corp. filed?

Zomedica Corp. (ZOMDF) has 8 DEFA14A (DEFA14A) filings on record, spanning Jan 2024 to Jun 2025.

What is a DEFA14A filing?

A DEFA14A is an SEC filing known as "DEFA14A." Additional definitive proxy soliciting materials filed alongside or after the main DEF 14A proxy statement.

Where can I read Zomedica Corp. DEFA14A filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Zomedica Corp. DEFA14A filings, including risk assessment, sentiment analysis, and key financial figures.

Zomedica Corp. (ZOMDF) — DEFA14A Filings

All DEFA14A filings from Zomedica Corp.. Browse 8 DEFA14A reports with AI-powered summaries and risk analysis.

DEFA14A Filings (8)

Zomedica Corp. Files Proxy Materials — Jun 6, 2025 Risk: low
Zomedica Corp. filed a Definitive Additional Materials proxy statement on June 6, 2025, related to its annual meeting. The company, previously known as Zomedica
Zomedica Corp. Files Definitive Additional Proxy Materials — May 30, 2025 Risk: low
Zomedica Corp. filed a Definitive Additional Materials proxy statement on May 30, 2025, related to its Schedule 14A filing. The company, previously known as Zom
Zomedica Corp. Files Additional Proxy Materials — May 13, 2025 Risk: low
Zomedica Corp. filed a Definitive Additional Materials (DEFA14A) proxy statement on May 13, 2025. This filing is related to the company's proxy materials and do
Zomedica Files Definitive Additional Proxy Materials — Feb 20, 2024 Risk: low
Zomedica Corp. filed a DEFA14A on February 20, 2024, indicating definitive additional proxy materials for an upcoming shareholder meeting. The filing, under SEC
Glass Lewis Backs Zomedica Reverse Stock Split Ahead of Feb 28 Vote — Feb 6, 2024
Zomedica Corp. (NYSE American: ZOM), a veterinary health company, announced on February 6, 2024, that Glass Lewis, a major independent proxy advisory firm, reco
Zomedica CEO Urges Shareholder Vote FOR Reverse Stock Split — Jan 31, 2024
Zomedica Corp. (NYSE American:ZOM) CEO Larry Heaton issued an open letter to shareholders on January 31, 2024, strongly encouraging them to vote FOR an upcoming
ISS Backs Zomedica Reverse Split to Maintain NYSE American Listing — Jan 26, 2024
Zomedica Corp. (NYSE American: ZOM), a veterinary health company, announced on January 25, 2024, that Institutional Shareholder Services (ISS) recommends shareh
Zomedica Touts $100M Cash, 40% Revenue Growth Ahead of Special Meeting — Jan 24, 2024
Zomedica Corp. (ZOM) filed a DEFA14A to provide additional materials for its upcoming Special Meeting, following a conference call on January 17, 2024. The comp

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX